Presented by:

NSGC Metabolism & Lysosomal Storage Diseases SIG
1. Billie Lianoglou, ScM, CGC

Learning Objectives:

1. Describe the clinical rationale and emerging evidence supporting prenatal intervention for severe monogenic disorders, with a focus on in utero enzyme replacement therapy for lysosomal storage diseases.
2. Review the design, implementation, and interim outcomes of the PEARL Trial, including patient selection, procedural considerations, and early safety and efficacy findings.
3. Recognize benefits and limits related to prenatal administration of AAV9 gene insertion for GM1 gangliosidosis including data from the pediatric experience and rationale for moving the intervention to the prenatal period.
4. Discuss the role of the UCSF Center for Genome Surgery in integrating genomic diagnosis, therapeutic development, and clinical translation to expand access to precision therapies for patients with rare genetic diseases.
5. Highlight emerging opportunities and challenges for genetic counselors as prenatal genomic therapies move from research into clinical practice.

As next-generation sequencing (NGS) becomes the standard of care, a laboratory's competitive advantage is no longer defined by the test itself, but by how effectively it leverages data, automation, and innovation. Laboratories that embrace AI, invest in scalable data infrastructure, and integrate intelligent workflows are better positioned to increase efficiency, expand testing capacity, and contribute to learning health systems.

Join us to explore how AI can be applied responsibly throughout the case review process. Discover which tasks can be automated, where human expertise delivers the greatest value, and how to achieve the right balance between efficiency and scientific oversight.

Presented by:

NSGC Genomic Technologies SIG
1. Talia Silver, MHSc

Learning Objectives:

1. Explain the technical layer of genomics lab operations.
2. Explain different forms of AI, where and how they can be used, and what guardrails can enable safe adoption in a lab setting.
3. Explain how automation, and utilization of software stand to improve lab operations.
4. Explain how structured data storage enables reanalysis and research and what it can enable for healthcare systems.

First-time attendees of the NSGC Annual Conference are invited to join this webinar for an overview of what to expect at the NSGC 45th Annual Conference. Learn more about NSGC membership benefits and programming, receive an overview of sessions to look forward to at this year's conference, and hear from recent graduates about their experience from attending the conference in the past. There will be time for Q&A at the end of the webinar. 

This event is exclusively for Annual Conference attendees who have registered to attend the First-Time Attendee Workshop and/or the First-Time Attendee Welcome Reception on Tuesday, Nov. 10. 

Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will present challenging cases, including a prenatal whole exome sequencing workup that led to variant reclassification, cascade testing across an extended family, and unexpected management implications for the pregnant patient; and a family undergoing repeated diagnostic and counseling shifts as new genetic evidence challenged established disease expectations. Together, these cases highlight evolving genetic knowledge, complex result interpretation, nuanced risk assessment, and the counseling strategies needed to support patients and families facing uncertainty.

Presented by:

1. Nour Chanouha, MS, CGC
2. Hannah S. Anderson, MS, CGC

Learning Objectives:

1. Evaluate complex genetic results disclosure plans based on multiple clinical and psychosocial factors.
2. Describe how family history, fetal phenotype, and evolving variant interpretation can guide the interpretation of prenatal genetic testing and inform recurrence risk and family management.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Case Based Webinar - Part IV. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

This all-inclusive package offers access to the full set of 24 webinars from NSGC’s 2026 Webinar Series, complete with CEUs. Please note that webinars will be added to this package as they are released.

To purchase the 2026 NSGC Webinar Series Full Package, click the blue "Register Now" button next to the package title. Do not register for the individual components included in the package.

Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 2.4 CEUs or 24 Category 1 contact hours for the 2026 NSGC Webinar Series Full Package. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Prenatal skeletal dysplasias are among the most challenging conditions to diagnose and counsel prenatally due to variable phenotypic expression, evolving genotype-phenotype correlations, and limitations of prenatal imaging and molecular testing. While advances in genomic technologies have improved diagnostic capabilities, predicting clinical outcomes, including survival, severity, and long-term prognosis, often remains uncertain.

This webinar will review current approaches to the prenatal evaluation of suspected skeletal dysplasias and explore the challenges of prognostication in the context of uncertain or evolving information. Through clinical cases, participants will examine practical counseling strategies for communicating uncertainty, supporting informed decision-making, and providing patient-centered care for families navigating complex prenatal diagnoses of skeletal dysplasia.

Presented by: 

NSGC Skeletal Dysplasia SIG
1. Shannon Persick, MS, CGC

Learning Objectives:

1. Review the most common prenatal presentations of skeletal dysplasias.
2. Describe the major factors that contribute to prognostic uncertainty in prenatal skeletal dysplasia evaluation, including limitations of ultrasound examination, molecular testing, and genotype phenotype correlations.
3. Illustrate the spectrum of clinical outcomes associated with prenatal skeletal dysplasia diagnoses through real-life case examples.
4. Recognize common psychosocial challenges experienced by families navigating a new diagnosis of skeletal dysplasia in both the prenatal and neonatal periods.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Prenatal Skeletal Dysplasias: Navigating Prognostic Uncertainty and Counseling Challenges. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

Advancements in genomic knowledge and next generation sequencing technologies have resulted in expanded carrier screening creating more equitable opportunities for individuals to learn about their reproductive risks for various genetic conditions including inherited eye and hearing conditions.  For many of the ocular and auditory conditions included in carrier screening panels there are wide spectrums of phenotypic features including age of onset and severity.  In this webinar, we discuss some common carrier screening findings for ocular and auditory conditions and offer strategies for providing a nuanced approach to genetic counseling about ocular and auditory conditions.

Presented by: 

NSGC Ophthalmology and Hearing Loss SIG
1. Shay Guetz-Lindahl, MS, CGC
2. Emily Place, MS, LCGC

Learning Objectives:

1. Define the spectrum of presentation of ocular genetic conditions found on carrier screening.
2. Define the spectrum of presentation of hearing loss genetic conditions on carrier screening.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Spectrum of Senses: Insights and Caveats for navigating ocular and auditory genetics in prenatal and preconception counseling. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Content expires December 31, 2027.

This webinar examines how genetic counselors are implementing pharmacogenomics (PGx) testing and counseling across healthcare settings. Over 95% of the population carries clinically significant pharmacogene variants, yet implementation lags behind other genetic testing due to limited workforce training, provider literacy gaps, and high clinical decision support costs. The presenters showcased three primary PGx service delivery models: academic medicine programs (Brigham & Women's Hospital telemedicine clinic and M Health Fairview's Go4PGx Initiative), private practice collaborations between genetic counselors and pharmacists, and laboratory-based models such as Color Health's integration with cancer clinics and research partnerships. Future challenges include managing increasingly complex sequencing-based and polygenic score PGx results while capitalizing on opportunities from long-read genomics and rapid sequencing technologies. Training programs and continuing education must expand to meet growing clinical integration of PGx and establish counselor competency as a hiring differentiator.

Presented by: 

NSGC Precision Medicine SIG
1. Hannah Llorin, MS, CGC
2. Elizabeth Fieg, MS, CGC
3. Hetanshi Naik, PhD, MS, CGC
4. Jen Eichmeyer, MS, CGC
5. Jeri Nichols, MS, PharmD, CGC, CSP
6. Carla McGruder, MS, CGC
7. Rissa Hall, MS, CGC

Learning Objectives:

1. Explain the clinical relevance and utility of pharmacogenomics (PGx)
2. Identify barriers to PGx implementation in genetic counseling practice and recognize emerging opportunities to advance the field
3. Compare genetic counselor roles and responsibilities across academic, private practice, and laboratory-based PGx models

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, From Niche to Necessary: Genetic Counselor-Led Pharmacogenomics Across the Care Continuum. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Genetic counselors are increasingly moving into roles in industry, diagnostics, digital health, research, and consulting—positions where leadership happens through influence, expertise, and strategic relationships rather than formal management. Yet professional development resources for GCs tend to focus on either clinical skill-building or early-career milestones. There is a gap in programming that speaks to:

• GCs who have led teams and are navigating a shift to peer-level influence

• GCs in industry or commercial roles who must lead without direct reports

• GCs asking how to articulate and leverage their leadership experience when a title change obscures it

• GCs at any stage wondering whether leadership is still part of their identity when the structure changes

This webinar meets GCs where they are—not with a generic leadership curriculum, but with a peer-to-peer conversation grounded in real role transitions within the genetics and diagnostics space.

Presented by: 

NSGC Leadership and Management SIG
1. Kelly Tangney, MS, CGC

Learning Objectives:

1. Distinguish between positional leadership (authority-based) and relational leadership (influence-based), and identify which model applies to your current role.
2. Recognize the leadership and management competencies you have already developed, and articulate how those competencies transfer across role types.
3. Apply at least two concrete strategies for leading effectively among peers and cross-functional partners without direct authority.
4. Describe how role transitions can lead to leadership evolution across role types.
5. Identify your next steps for continued professional growth as a leader, regardless of title or organizational structure.

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Leading Without the Title:  How Genetic Counselors Can Navigate Leadership Across Changing Roles. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation

Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.

Presented by:

1. Chenery Lowe, ScM, CGC, PhD
2. Lauren Puryear, MS, CGC
3. Brittany Sears, PhD, MSPH, LCGC

Learning Objectives:

1. Identify patient’s stated and unstated goals for genetic testing.
2. Design a genetic testing strategy that meets both patient’s stated and unstated goals.
3. Identify strategies to navigate ethical conflicts regarding personal autonomy, disclosure timelines, and parental authority when managing genetic testing without assent in pediatric populations.
4. Determine ethically permissible options for reproductive decisions informed by reproductive, disability, and professional ethics frameworks

Genetic Counselor CEUs: 

The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Case Based Webinar - Part III. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

Successful Completion: 

1. View recording
2. Pass quiz
3. Complete evaluation